Treatment of basal cell epithelioma by curettage and electrodesiccation

doi:10.1016/S0190-9622(84)80457-0

Journal of the American Academy of Dermatology

Volume 11, Issue 5, Part 1, November 1984, Pages 808-814

https://doi.org/10.1016/S0190-9622(84)80457-0 Get rights and content

A total of 233 biopsy-proved basal cell epitheliomas (BCEs) treated by curettage and electrodesiccation (C&D) in our office in 1976 and 1977 were followed a minimum of 5 years. There were seven recurrences, a cure rate of 97.0%. Our results, both for recurrence rates and cosmetic appearance, varied according to the size and location of the cancers. The cosmetic results were generally excellent especially in the smaller cancers. Smaller BCEs'less than 2 cm diameter, excluding the nose and nasolabial area, had our highest cure rate, 99.4% (171/172). Our treatment method is described in detail. Although not a complicated procedure, C&D does require skill, thoroughness and selection of patients to achieve high cure rates and is still an excellent treatment choice for many BCEs.

References (30)

SJ Salasche
Curettage and electrodesiccation in the treatment of midfacial basal cell epithelioma
J Am Acad Dermatol
(1983)
BL Edens et al.
Effectiveness of curettage and electrodesiccation in the removal of basal cell carcinoma
J Am Acad Dermatol
(1983)
C Camisa et al.
Monsel solution tattooing (Letter to Editor.)
J Am Acad Dermatol
(1983)
SJ Salasche
Status of curettage and desiccation in the treatment of primary basal cell carcinoma
J Am Acad Dermatol
(1984)
NA Brooks
Curettage and shave excision
J Am Acad Dermatol
(1984)
JM Knox et al.
Curettage and electrodesiccation in the treatment of skin cancer
Arch Dermatol
(1960)
AW Kopf et al.
Curettageelectrodesiccation treatment of basal cell carcinomas
Arch Dermatol
(1977)
RD Sweet
The treatment of basal-cell carcinoma by curettage
Br J Dermatol
(1963)
JM Knox et al.
Treatment of skin cancer
South Med J
(1967)
JT Crissy
Curettage and electrodesiccation as a method of treatment for epitheliomas of the skin
J Surg Oncol
(1971)

R Jackson

The treatment of basal-cell carcinomas

Cutis

(1969)

LB Shanoff et al.

Basal-cell carcinoma: A statistical approach to rational management

Plast Reconstr Surg

(1962)

GS Williamson et al.

Treatment of basal-cell carcinoma by electrodesiccation and curettage

Can Med Assoc J

(1962)

N Dubin et al.

Multivariate risk score for recurrence of cutaneous basal cell carcinomas

Arch Dermatol

(1983)

WE McDaniel

Therapy for basal cell epitheliomas by curettage only

Arch Dermatol

(1983)

Cited by (81)

Diagnosis and Treatment of Basal Cell Carcinoma in Specialized Dermatology Units: A Clinical Practice Guideline
2020, Actas Dermo-Sifiliograficas
El carcinoma basocelular supone el cáncer de piel más frecuente en la población. Hay una gran variabilidad en su manejo y las diferentes guías extranjeras que existen son difícilmente aplicables en nuestro medio. El objetivo de la presente guía es servir de referencia a los dermatólogos españoles para mejorar el manejo de este tumor basándose en la evidencia actual.
Se escogió a miembros del Grupo Español de Dermato-Oncología y Cirugía (GEDOC) con experiencia en el tratamiento de estos tumores y con interés en participar en la elaboración de la guía. Se hizo una adaptación de las guías de práctica clínica existentes mediante el método ADAPTE, se resumió el proceso de atención, y se elaboraron las preguntas clínicas relevantes. Se seleccionaron las guías mejor puntuadas mediante el instrumento AGREE II, realizando la búsqueda de las respuestas en dichas guías y elaborando posteriormente las recomendaciones. Finalmente se sometió la guía a revisión externa.
Las guías con mejor puntuación fueron las de la British Association of Dermatologits (BAD), del National Comprehensive Cancer Network (NCCN), del European Dermatology Forum (EDF) y de la European Academy of Dermatology and Venereology (EADV). Se obtuvieron en total 11 preguntas clínicas, contestadas a partir de estas guías.
Esta guía responde a preguntas habituales sobre el manejo del carcinoma basocelular en la práctica clínica diaria y sirve a los dermatólogos como referencia en la toma de decisiones, siempre teniendo en cuenta los recursos y las preferencias del paciente.
Basal cell carcinoma (BCC) is the most common skin cancer in the general population. BCC is managed in a variety of ways, and available international guidelines are difficult to put into practice in Spain. This guideline aims to improve the management of BCC based on current evidence and provide a point of reference for Spanish dermatologists.
Members of the Spanish Oncologic Dermatology and Surgery Group (GEDOC) with experience treating BCC were invited to participate in drafting this guideline. The drafters used the ADAPTE collaboration process to develop the new guideline based on existing ones, first summarizing the care pathway and posing relevant clinical questions. They then searched for guidelines, assessed them with the AGREE II (Appraisal of Guidelines for Research and Evaluation) tool, and searched the selected guidelines for answers to the clinical questions. Finally, the recommendations were drafted and submitted for external review.
The highest-scoring guidelines were from the Association of Dermatologists, the National Comprehensive Cancer Network, the European Dermatology Forum, and the European Academy of Dermatology and Venereology. A total of 11 clinical questions were answered.
This new guideline answers the working group's clinical questions about the routine management of BCC in Spain. It provides dermatologists with a tool they can use for decision-making while taking into consideration the resources available and patient preferences.
Review and Update on Evidence-Based Surgical Treatment Recommendations for Nonmelanoma Skin Cancer
2019, Dermatologic Clinics
Basal cell carcinoma: Contemporary approaches to diagnosis, treatment, and prevention
2019, Journal of the American Academy of Dermatology
As the most common human cancer worldwide and continuing to increase in incidence, basal cell carcinoma is associated with significant morbidity and cost. Continued advances in research have refined both our insight and approach to this seemingly ubiquitous disease. This 2-part continuing medical education series provides a comprehensive and contemporary review of basal cell carcinoma. The second article in this series will present both the current standard of care and newly developed approaches to diagnosis, treatment, and prevention of this disease.
Treatment of Basal Cell Carcinoma in the Elderly: What Nondermatologists Need to Know
2016, American Journal of Medicine
As the population ages and incidence of basal cell carcinoma continues to increase, we will be faced more frequently with difficult treatment decisions for basal cell carcinoma in the elderly. Different treatment options, including surgical excision, electrodessication and curettage, cryosurgery, imiquimod, photodynamic therapy, 5-fluorouracil, radiation therapy, vismodegib, combination therapy, and observation, may be considered on the basis of tumor characteristics. Given the wide range of therapeutic options, treatments can be tailored to achieve patients' goals of care within their anticipated life expectancy.
An overview of the medical management of nonmelanoma skin cancer
2015, Current Problems in Cancer
Citation Excerpt :
Although effective, topical therapy remains inferior to electrodessication and curettage. Its recurrence data are reportedly between 0.6% and 7.3%.33-35 Ingenol mebutate was the subject of a phase II trial for treatment of superficial BCCs.
Nonmelanoma Skin Cancer of the Head and Neck: Nonsurgical Treatment
2012, Facial Plastic Surgery Clinics of North America

View all citing articles on Scopus

View full text

Treatment of basal cell epithelioma by curettage and electrodesiccation

J Am Acad Dermatol

J Am Acad Dermatol

J Am Acad Dermatol

J Am Acad Dermatol

J Am Acad Dermatol

Curettage and electrodesiccation in the treatment of skin cancer

Arch Dermatol

Curettageelectrodesiccation treatment of basal cell carcinomas

Arch Dermatol

The treatment of basal-cell carcinoma by curettage

Br J Dermatol

Treatment of skin cancer

South Med J

Curettage and electrodesiccation as a method of treatment for epitheliomas of the skin

J Surg Oncol

The treatment of basal-cell carcinomas

Cutis

Basal-cell carcinoma: A statistical approach to rational management

Plast Reconstr Surg

Treatment of basal-cell carcinoma by electrodesiccation and curettage

Can Med Assoc J

Multivariate risk score for recurrence of cutaneous basal cell carcinomas

Arch Dermatol

Therapy for basal cell epitheliomas by curettage only

Arch Dermatol